Editor-in-Chief: Guang-Wen Cao
Indexing: ESCI, CAS, Scopus, Embase, etc.,
Journal Rank: CiteScore 3.2 - Impact Factor 1.7, Q3 (Gastroenterology & Hepatology)
Submission to first decision: 74 days

Hepatoma Research

Articles

Most Recent | Most Viewed | Most Downloaded

Screening for lipid metabolism-related genes and identifying the therapeutic potential of ACACA for ER stress-related progression in hepatocellular carcinoma

Abstract:
Aim: The reprogramming of lipid metabolism can markedly enhance the nutritional adaptability of tumor cells to the glucose-deficient and hypoxic tumor... MORE
Open Access Original Article DOI: 10.20517/2394-5079.2024.135 28 May 2025
Views: 30 Downloads: 1
Download PDF 0 0

Predicting microvascular invasion plus cytokeratin 19 expression positivity in hepatocellular carcinoma based on EOB-MRI using multitask deep learning

Abstract:
Aim: To construct and validate a multitask deep learning (DL) model based on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)... MORE
Open Access Original Article DOI: 10.20517/2394-5079.2024.143 26 Apr 2025
Views: Downloads:
Download PDF

HCC in MASLD: radiological appearance, diagnosis and treatment

Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), are... MORE
Open Access Review DOI: 10.20517/2394-5079.2024.117 22 Apr 2025
Views: Downloads:
Download PDF

The interaction effect between key autophagy-related biomarkers and HBV/HCV infections on the survival prognosis of hepatocellular carcinoma

Abstract:
Aim: This study aimed to investigate the prognostic and diagnostic value of autophagy-related genes (ATGs) in hepatocellular carcinoma... MORE
Open Access Original Article DOI: 10.20517/2394-5079.2024.129 20 Mar 2025
Views: Downloads:
Download PDF

Surveillance for patients at risk of hepatocellular carcinoma: how to improve its cost-effectiveness and expand the role of multidisciplinary tumor board?

Abstract:
Surveillance for hepatocellular carcinoma (HCC) improves early tumor detection, increases access to curative therapies, and reduces mortality by about 40%.... MORE
Open Access Review DOI: 10.20517/2394-5079.2024.136 13 Mar 2025
Views: Downloads:
Download PDF

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease

Abstract:
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. This term does not describe the pathogenetic mechanisms and... MORE
Open Access Review DOI: 10.20517/2394-5079.2023.134 28 Mar 2024
Views: Downloads:
Download PDF

Issue on combined locoregional and systemic treatment for hepatocellular carcinoma

Abstract:
Treatment for hepatocellular carcinoma (HCC) has been challenging as most patients present with late, advanced disease, where curative options are limited. For... MORE
Open Access Review DOI: 10.20517/2394-5079.2022.37 15 Mar 2023
Views: Downloads:
Download PDF

Barriers to surveillance for hepatocellular cancer among patients with chronic liver disease -providers' perspectives

Abstract:
Aims: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. While patients who are known to be at high risk for HCC should be... MORE
Open Access Original Article DOI: 10.20517/2394-5079.2023.75 29 Oct 2023
Views: Downloads:
Download PDF
1 / 23
The Selection Committee of Hepatoma Research has identified five papers as exemplary contributions
This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.
Hepatoma Research received its first impact factor of 1.7! It is ranked in the Q3 quartile within the field of Gastroenterology & Hepatology.
Hepatoma Research achieved a remarkable CiteScore of 3.2 for 2023, a significant improvement from 2.5 in 2022.
Hepatoma Research is delighted to announce the appointment of six world-renowned scientists to serve as Associate Chief Editors.
The Selection Committee of Hepatoma Research has identified five papers as exemplary contributions
This prestigious ranking identifies the top 2% of scientists globally from over 7 million scientists, spanning 22 fields and 174 sub-disciplines.
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/